Skip to content

Robert Lechleider, Chief Medical Officer at Immunome, sold IMNM on Jun 25, 2026

Data as of Oct 16

▼ SELL$298K14,420 shares at $20.66Robert Lechleider Chief Medical OfficerIMNM Immunome Inc.
Watch IMNM
Traded
Jun 25, 2026
Disclosed
Jun 29, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Robert Lechleider, Chief Medical Officer at Immunome, sold IMNM on Jun 25, 2026TRADEDDISCLOSED
IMNMSimilar stocks (XLV — its sector index fund), rebased to IMNM's price on the disclosure day
IMNM since disclosure
−21.7%
after the sale
Similar stocks (XLV) since disclosure
+9.9%
XLV — its sector index fund

Change in closing price from Jun 29, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLRobert Lechleider Chief Medical OfficerIMNM Immunome Inc.$794Kdisclosed Jun 29 · filed 4 days after the trade

See every trade on IMNM →